Safety and efficacy of dual therapy with daclatasvir and asunaprevir for patients with chronic Hepatitis C
Latest Information Update: 10 Jan 2017
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Jan 2017 Status changed from recruiting to completed.
- 22 Jun 2016 New trial record